Annual SG&A
$6.24 M
-$2.75 M-30.58%
31 December 2023
Summary:
Annovis Bio annual selling, general & administrative expenses is currently $6.24 million, with the most recent change of -$2.75 million (-30.58%) on 31 December 2023. During the last 3 years, it has risen by +$2.66 million (+74.12%). ANVS annual SG&A is now -30.58% below its all-time high of $9.00 million, reached on 31 December 2022.ANVS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.70 M
-$279.30 K-14.12%
30 September 2024
Summary:
Annovis Bio quarterly selling, general & administrative expenses is currently $1.70 million, with the most recent change of -$279.30 thousand (-14.12%) on 30 September 2024. Over the past year, it has increased by +$672.50 thousand (+65.57%). ANVS quarterly SG&A is now -45.29% below its all-time high of $3.10 million, reached on 31 March 2022.ANVS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$466.92 M
-$40.94 M-9.61%
30 September 2024
Summary:
Annovis Bio TTM selling, general & administrative expenses is currently -$466.92 million, with the most recent change of -$40.94 million (-9.61%) on 30 September 2024. Over the past year, it has dropped by -$473.21 million (-7512.90%). ANVS TTM SG&A is now -5896.87% below its all-time high of $10.44 million, reached on 30 September 2022.ANVS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANVS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.6% | +65.6% | -7512.9% |
| 3 y3 years | +74.1% | +15.3% | -10000.0% |
| 5 y5 years | +936.8% | +608.1% | -10000.0% |
ANVS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -30.6% | +74.1% | -45.3% | +65.6% | -527.1% | at low |
| 5 y | 5 years | -30.6% | +936.8% | -45.3% | +1460.8% | -1329.6% | at low |
| alltime | all time | -30.6% | +1426.4% | -45.3% | +1460.8% | -5896.9% | at low |
Annovis Bio Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.70 M(-14.1%) | $6.51 M(+11.5%) |
| June 2024 | - | $1.98 M(+52.7%) | $5.84 M(+9.0%) |
| Mar 2024 | - | $1.29 M(-15.8%) | $5.36 M(-14.2%) |
| Dec 2023 | $6.24 M(-30.6%) | $1.54 M(+49.9%) | $6.24 M(-0.9%) |
| Sept 2023 | - | $1.03 M(-31.5%) | $6.30 M(-17.5%) |
| June 2023 | - | $1.50 M(-31.4%) | $7.63 M(-5.5%) |
| Mar 2023 | - | $2.18 M(+37.2%) | $8.08 M(-10.2%) |
| Dec 2022 | $9.00 M(+48.5%) | $1.59 M(-32.6%) | $9.00 M(-13.8%) |
| Sept 2022 | - | $2.36 M(+21.8%) | $10.44 M(+9.3%) |
| June 2022 | - | $1.94 M(-37.6%) | $9.55 M(+14.8%) |
| Mar 2022 | - | $3.10 M(+2.2%) | $8.32 M(+37.4%) |
| Dec 2021 | $6.06 M | $3.04 M(+106.1%) | $6.06 M(+72.1%) |
| Sept 2021 | - | $1.47 M(+107.6%) | $3.52 M(+20.1%) |
| June 2021 | - | $709.60 K(-15.5%) | $2.93 M(-25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $839.60 K(+68.8%) | $3.91 M(+9.0%) |
| Dec 2020 | $3.59 M(+332.4%) | $497.50 K(-43.8%) | $3.59 M(+12.2%) |
| Sept 2020 | - | $884.90 K(-47.6%) | $3.20 M(+25.3%) |
| June 2020 | - | $1.69 M(+226.5%) | $2.55 M(+119.0%) |
| Mar 2020 | - | $516.70 K(+374.9%) | $1.17 M(+40.5%) |
| Dec 2019 | $829.40 K(+37.7%) | $108.80 K(-54.6%) | $829.40 K(-5.3%) |
| Sept 2019 | - | $239.80 K(-20.1%) | $875.40 K(+15.2%) |
| June 2019 | - | $300.00 K(+65.9%) | $760.10 K(+16.8%) |
| Mar 2019 | - | $180.80 K(+16.8%) | $651.00 K(+8.1%) |
| Dec 2018 | $602.30 K(+47.2%) | $154.80 K(+24.3%) | $602.40 K(+34.6%) |
| Sept 2018 | - | $124.50 K(-34.8%) | $447.60 K(+38.5%) |
| June 2018 | - | $190.90 K(+44.4%) | $323.10 K(+144.4%) |
| Mar 2018 | - | $132.20 K | $132.20 K |
| Dec 2017 | $409.10 K | - | - |
FAQ
- What is Annovis Bio annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Annovis Bio?
- What is Annovis Bio annual SG&A year-on-year change?
- What is Annovis Bio quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Annovis Bio?
- What is Annovis Bio quarterly SG&A year-on-year change?
- What is Annovis Bio TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Annovis Bio?
- What is Annovis Bio TTM SG&A year-on-year change?
What is Annovis Bio annual selling, general & administrative expenses?
The current annual SG&A of ANVS is $6.24 M
What is the all time high annual SG&A for Annovis Bio?
Annovis Bio all-time high annual selling, general & administrative expenses is $9.00 M
What is Annovis Bio annual SG&A year-on-year change?
Over the past year, ANVS annual selling, general & administrative expenses has changed by -$2.75 M (-30.58%)
What is Annovis Bio quarterly selling, general & administrative expenses?
The current quarterly SG&A of ANVS is $1.70 M
What is the all time high quarterly SG&A for Annovis Bio?
Annovis Bio all-time high quarterly selling, general & administrative expenses is $3.10 M
What is Annovis Bio quarterly SG&A year-on-year change?
Over the past year, ANVS quarterly selling, general & administrative expenses has changed by +$672.50 K (+65.57%)
What is Annovis Bio TTM selling, general & administrative expenses?
The current TTM SG&A of ANVS is -$466.92 M
What is the all time high TTM SG&A for Annovis Bio?
Annovis Bio all-time high TTM selling, general & administrative expenses is $10.44 M
What is Annovis Bio TTM SG&A year-on-year change?
Over the past year, ANVS TTM selling, general & administrative expenses has changed by -$473.21 M (-7512.90%)